Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00199381 · ClinicalTrials.gov registry record · Phase 3
An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001
A Phase 3 study, sponsored by Kyowa Kirin.
- Terminated
- Registry status
- Phase 3
- Development phase
- 504
- Enrollment target
NCT00199381 is a Phase 3 study that was terminated before completion, run by Kyowa Kirin. The registered enrollment target is 504 participants.
The verdict
NCT00199381, a Phase 3 study, was terminated before completion, sponsored by Kyowa Kirin.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 504 participants
- Enrollment target
Study Summary
This is an, open-label, long-term safety extension for patients in North America who have completed the prior istradefylline study 6002-INT-001.
Interventions
- DRUG Istradefylline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 504 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00199381
The ClinicalTrials.gov registry entry for NCT00199381 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 504 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Istradefylline is the first listed.
NCT00199381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00199381 about?
NCT00199381 is a clinical study titled "An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001". This is an, open-label, long-term safety extension for patients in North America who have completed the prior istradefylline study 6002-INT-001.
What is the current status of trial NCT00199381?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 504 participants. The study started on 2005-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00199381?
The interventions under investigation include: Istradefylline (DRUG).
Who is sponsoring clinical trial NCT00199381?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.